Gene · 9536
Papers2,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacological mechanisms of sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: A systematic review. | Phytomedicine | 2023 | 37816287 | PubTator, text mining | PubMed |
| 3D in vitro hydrogel models to study the human lung extracellular matrix and fibroblast function. | Respir Res | 2023 | 37798767 | PubTator, text mining | PubMed |
| Fluid flow shear stress and tissue remodeling-an orthodontic perspective: evidence synthesis and differential gene expression network analysis. | Front Bioeng Biotechnol | 2023 | 37795174 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
| The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages. | Int J Biol Sci | 2023 | 37781517 | PubTator, text mining | PubMed |
| Macroarray expression analysis of cytokines and prostaglandin metabolism-related genes in chronic rhinosinusitis. | J Allergy Clin Immunol Glob | 2023 | 37779524 | PubTator, text mining | PubMed |
| Epidemiologic Study of Gene Distribution in Romanian and Brazilian Patients with Non-Cicatricial Alopecia. | Medicina (Kaunas) | 2023 | 37763773 | PubTator, text mining | PubMed |
| Inflammation-related signaling pathways in tendinopathy. | Open Life Sci | 2023 | 37744452 | PubTator, text mining | PubMed |
| The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment. | Front Pharmacol | 2023 | 37731742 | PubTator, text mining | PubMed |
| BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma. | Mol Med | 2023 | 37710185 | PubTator, text mining | PubMed |
| Primary hypertrophic osteoarthropathy: genetics, clinical features and management. | Front Endocrinol (Lausanne) | 2023 | 37705574 | PubTator, text mining | PubMed |
| Microsomal glutathione transferase 1 in cancer and the regulation of ferroptosis. | Adv Cancer Res | 2023 | 37704286 | PubTator, text mining | PubMed |
| Evaluation of Anticancer and Anti-Inflammatory Activities of Some Synthetic Rearranged Abietanes. | Int J Mol Sci | 2023 | 37686389 | PubTator, text mining | PubMed |
| Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators. | Front Pharmacol | 2023 | 37680719 | PubTator, text mining | PubMed |
| Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases. | Stem Cell Res Ther | 2023 | 37667383 | PubTator, text mining | PubMed |
| Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approach. | Medicine (Baltimore) | 2023 | 37657050 | PubTator, text mining | PubMed |
| "Of mice and men": the relevance of Cometin and Erythropoietin origin for its effects on murine spiral ganglion neuron survival and neurite outgrowth in vitro. | Front Neurosci | 2023 | 37638326 | PubTator, text mining | PubMed |
| Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors. | Saudi Pharm J | 2023 | 37638222 | PubTator, text mining | PubMed |
| Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. | Signal Transduct Target Ther | 2023 | 37635168 | PubTator, text mining | PubMed |
| Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis. | J Autoimmun | 2023 | 37633117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9536/papers?page=10